Prevalence and Characteristics of Metabolic Syndrome Differ in Men and Women with Early Rheumatoid Arthritis.


Journal

ACR open rheumatology
ISSN: 2578-5745
Titre abrégé: ACR Open Rheumatol
Pays: United States
ID NLM: 101740025

Informations de publication

Date de publication:
11 2019
Historique:
entrez: 29 11 2019
pubmed: 30 11 2019
medline: 30 11 2019
Statut: epublish

Résumé

Metabolic syndrome (MetS) prevalence in early rheumatoid arthritis (ERA) is conflicting. The impact of sex, including menopause, has not been described. We estimated the prevalence and factors associated with MetS in men and women with ERA. A cross-sectional study of the Canadian Early Arthritis Cohort (CATCH) was performed. Participants with baseline data to estimate key MetS components were included. Sex-stratified logistic regression identified baseline variables associated with MetS. The sample included 1543 participants; 71% were female and the mean age was 54 (SD 15) years. MetS prevalence was higher in men 188 (42%) than women 288 (26%, The characteristics and associations of MetS differed in men and women with ERA. Sex differences, including postmenopausal status, should be considered in comorbidity screening. With this knowledge, the interplay of MetS, sex, and RA therapeutic response on cardiovascular outcomes should be investigated.

Identifiants

pubmed: 31777836
doi: 10.1002/acr2.11075
pii: ACR211075
pmc: PMC6858015
doi:

Types de publication

Journal Article

Langues

eng

Pagination

535-541

Commentaires et corrections

Type : ErratumIn
Bartlett, S [corrected to Bartlett, SJ]

Informations de copyright

© 2019 The Authors. ACR Open Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology.

Références

BMC Med. 2011 May 05;9:48
pubmed: 21542944
Menopause. 2018 Oct;25(10):1155-1164
pubmed: 29787477
J Affect Disord. 2019 Feb 1;244:25-32
pubmed: 30296663
Arthritis Rheum. 2008 Dec 15;59(12):1690-7
pubmed: 19035419
Int J Clin Exp Med. 2014 Aug 15;7(8):2258-65
pubmed: 25232418
PLoS One. 2017 Mar 23;12(3):e0170361
pubmed: 28333949
Nat Rev Rheumatol. 2014 Nov;10(11):691-6
pubmed: 25090948
Arthritis Res Ther. 2015 Feb 20;17:34
pubmed: 25889060
Maturitas. 2010 Mar;65(3):262-6
pubmed: 19962253
Arthritis Care Res (Hoboken). 2015 May;67(5):616-23
pubmed: 25303739
J Affect Disord. 2019 Feb 1;244:54-59
pubmed: 30316052
Arthritis Res Ther. 2010;12(6):R218
pubmed: 21182767
Rheumatol Int. 2017 Jan;37(1):21-27
pubmed: 27084374
Pharmacol Res. 2017 Jun;120:34-42
pubmed: 28300617
Rheumatology (Oxford). 2016 Oct;55(10):1751-62
pubmed: 27330161
Can J Cardiol. 2016 May;32(5):569-88
pubmed: 27118291

Auteurs

B Kuriya (B)

Sinai Health System University of Toronto CA.

O Schieir (O)

Dalla Lana School of Public Health University of Toronto Toronto CA.

M F Valois (MF)

McGill University Montreal CA.

J E Pope (JE)

Western University London CA.

G Boire (G)

Université de Sherbrooke Sherbrooke CA.

L Bessette (L)

Université de Laval Quebec CA.

G Hazlewood (G)

University of Calgary Calgary CA.

J C Thorne (JC)

Southlake Regional Health Center Newmarket CA.

D Tin (D)

Southlake Regional Health Center Newmarket CA.

C Hitchon (C)

University of Manitoba Winnipeg CA.

S J Bartlett (SJ)

McGill University Montreal CA.
Johns Hopkins School of Medicine Baltimore USA.

E C Keystone (EC)

Sinai Health System University of Toronto CA.

V P Bykerk (VP)

Hospital for Special Surgery Weill Cornell Medical College New York USA.

L Barra (L)

Western University London CA.

Classifications MeSH